Scadenza: 2 April 2021
Scadenze successive:
Open for submissions from 4 March 2021,
Topic:
Our goal is to support research that seeks to answer the difficult questions in cancer biology. What we are looking for in an application:
innovative research that takes intellectual risks
ideas which have the potential to start new lines of research and to tell us something new about cancer and how it could be prevented, diagnosed or treated
proposals with a creative approach to answering fundamental questions that could change how we think about cancer
grants support fundamental or translational research into the prevention, diagnosis or treatment of cancer
Ente finanziatore:
Worldwide cancer research
Duration of the project: 3 years
Who can participate:
The PI must be employed at a recognised, non-profit research institution. Honorary contracts and emeritus positions are usually acceptable.
The PI is usually be a PhD-qualified tenured or tenure-track research group leader. Other suitably qualified persons, e.g. medical doctors, with appropriate research experience may also apply as the PI. Post-doctoral researchers with more than three years postdoctoral research experience at the time of application are also eligible to apply for a grant. Post-doctoral applicants who are not yet independent principal investigators must name their group head as co-applicant on the grant. Principal investigators who have established their first research group within the past 3 years are advised to add their head of department as a co-applicant. As a co-applicant, group heads or head of departments must have a minimum contribution of 5%, which could be as a mentor.
Other senior researchers who would be substantially involved in managing the project can be included as co-applicants. Co-applicants should be at senior post-doctoral level or above (i.e. with greater than 3-years post-doctoral research experience). Co-applicants do not need to be at the same institution as the PI.
Partnership: Not Mandatory
Status:
Closed
Quota finanziabile:
Max £ 250.000
Topic:
Our goal is to support research that seeks to answer the difficult questions in cancer biology. What we are looking for in an application:
innovative research that takes intellectual risks
ideas which have the potential to start new lines of research and to tell us something new about cancer and how it could be prevented, diagnosed or treated
proposals with a creative approach to answering fundamental questions that could change how we think about cancer
grants support fundamental or translational research into the prevention, diagnosis or treatment of cancer
Who can participate:
The PI must be employed at a recognised, non-profit research institution. Honorary contracts and emeritus positions are usually acceptable.
The PI is usually be a PhD-qualified tenured or tenure-track research group leader. Other suitably qualified persons, e.g. medical doctors, with appropriate research experience may also apply as the PI. Post-doctoral researchers with more than three years postdoctoral research experience at the time of application are also eligible to apply for a grant. Post-doctoral applicants who are not yet independent principal investigators must name their group head as co-applicant on the grant. Principal investigators who have established their first research group within the past 3 years are advised to add their head of department as a co-applicant. As a co-applicant, group heads or head of departments must have a minimum contribution of 5%, which could be as a mentor.
Other senior researchers who would be substantially involved in managing the project can be included as co-applicants. Co-applicants should be at senior post-doctoral level or above (i.e. with greater than 3-years post-doctoral research experience). Co-applicants do not need to be at the same institution as the PI.
Programme:
Consortium: Not required
Status: Open
Total budget:
Funding rate:
Max £ 250.000
Notes:
A research group can only submit one application per grant round.
If the principal investigator has previously applied for funding from Worldwide Cancer Research, any new application submitted must have a sufficiently different (at least 50%) research proposal compared to their previous proposals.
If you wish to re-submit a project (or one very similar) that has been rejected in the most recent grant round, but had passed preliminary triage review, you can re-apply as a in the next grant round.
policy on funding animal research states that we will not fund animal research projects in countries or institutions that do not in our view have sufficient controls on laboratory animal welfare. For animals research project the country must be pre-approved under Worldwide cancer research policy.
Worldwide Cancer Research will only accept the first 500 applications submitted in the grant round.
